Research Highlights: Explanation for <i>HLA-B*57:01</i> -linked immune-mediated abacavir-induced hypersensitivity-Reference-Cited by-同舟云学术

Research Highlights: Explanation for HLA-B*57:01 -linked immune-mediated abacavir-induced hypersensitivity

Published:2012-11 Issue:14 Volume:13 Page:1567-1569
ISSN:1462-2416
Container-title:Pharmacogenomics
language:en
Short-container-title:Pharmacogenomics

Author:

Alfirevic Ana¹,Park B Kevin¹,Pirmohamed Munir¹,Naisbitt Dean J¹

Affiliation:

1. The Wolfson Centre for Personalised Medicine, Department of Molecular & Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Block A: Waterhouse Buildings, 1–5 Brownlow Street, Liverpool, L69 3GL, UK

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.2217/pgs.12.146

Reference7 articles.

1. Avidity determines T‐cell reactivity in abacavir hypersensitivity

2. Human Leukocyte Antigen Class I-Restricted Activation of CD8+ T Cells Provides the Immunogenetic Basis of a Systemic Drug Hypersensitivity

3. Immune self-reactivity triggered by drug-modified HLA-peptide repertoire

4. Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire

5. Abacavir induces loading of novel self-peptides into HLA-B*57

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drugs for rare disorders;British Journal of Clinical Pharmacology;2017-06-27

2. Genetic Predictors of Drug Hypersensitivity;Current Pharmaceutical Design;2017-01-17

3. Recent advances in biomarkers and therapeutic interventions for hepatic drug safety – false dawn or new horizon?;Expert Opinion on Drug Safety;2016-03-17

4. Personalisierte Arzneitherapie auf genetischer Grundlage;Der Internist;2016-02-01

5. Pharmacogenetics of Adverse Drug Reactions;Advances in Predictive, Preventive and Personalised Medicine;2015